Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Missouri › St. Louis
Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma St. Louis, MO keessatti
Qorannoo 8 Diffuse Large B-Cell Lymphoma f St. Louis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Namoota walitti qabaa jiraSadarkaa 2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- fi 2 dabalataa
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Namoota walitti qabaa jiraSadarkaa 3
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · Miili 15 fagaatti
- Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · Miili 16 fagaatti
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Namoota walitti qabaa jiraSadarkaa 2
- Cancer Care Specialists of Central Illinois, Swansea · Miili 13 fagaatti
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
Namoota walitti qabaa jiraSadarkaa 2
- Washington University, St. Louis, St Louis
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Namoota walitti qabaa jiraSadarkaa 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- fi 2 dabalataa
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Namoota walitti qabaa jiraSadarkaa 2
- Siteman Cancer Center at Washington University, St Louis
Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti
- New York City, NYQorannoo 21
- Baldwin Park, CAQorannoo 19
- Chicago, ILQorannoo 18
- Houston, TXQorannoo 17
- Los Angeles, CAQorannoo 17
- Milwaukee, WIQorannoo 16
- Boston, MAQorannoo 16
- Nashville, TNQorannoo 15
- Philadelphia, PAQorannoo 15
- Portland, ORQorannoo 15
- Durham, NCQorannoo 14
- Dallas, TXQorannoo 13
Qorannoo biroo St. Louis keessatti
- Kansara Qara'a Non-Small CellQorannoo 73
- Saree OljooQorannoo 64
- Kansara MetastatikiiQorannoo 54
- Kansarii ColorectalQorannoo 50
- Saree (Gosoota Hunda)Qorannoo 46
- Kansarii ProstateQorannoo 46
- Dhibee QaraQorannoo 39
- Kansarii OvariiQorannoo 38
- Kansarii PancreasQorannoo 33
- Kansa EndometiriyaaliiQorannoo 29
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 28
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.